
July 24, 2001
Conference Call Notes
Lucent Technologies Inc.
- Announced
more than 2.5 billion in contracts during the last month. Backlogs
continue to increase.
- Gross
Margin constrained by low sales and various contract write-downs. Focus on
large Service Providers will help gross margins. Lucent is not ready to
quantify yet.
- Taking
aggressive cost reduction actions. Some are already paying off. They are watching every discretionary
expense.
- Research
and Development decreased 18 % sequentially from last year. R & D is
13.6 % of Revenues.
- Loss
of 1.89 billion on Gaap basis.
- Continues
to move forward with Agere spin-off. Looking to amend credit facilities.
Agere will be delayed upwards of 6 months. Different avenues maybe
pursued.
- Cash
Flow from operating activities has improved by 1.40 billion dollars.
- Inventory
declined 1.1 billion dollars. This included a write-down and better
inventory management.
- Domestic
vs. International was 65/35 vs. 70/30 last quarter. Overall outside USA
revenues increased, primarily due to China. USA revenues decreased 14 %
sequentially, primarily because of US slowdown.
- Total
Commitments on vendor financing declined about 1.4 billion.
- Cash
Flow from operations improved by 1.4 billion. Depreciation and
Amortization remained steady at 650 million. Capex was 350 million.
Financing cash flow was 1.1 billion. WE NEED TO SEE 10Q (my notes).
- Dividend
eliminated immediately.
- Non-cash
charge of 1.2 billion in Q4 by recent employee reduction measures.
- Announced
sale of 600 to 650 mil to Celestica. This should help Gross Margins. Also,
announced sale of fiber optic manufacturing for 2.75 billion. This gives
cash as well as some additional joint ventures.
- Pleased
with results of previous 7 point plan. They would like to use further
measures to radically accelerate Lucent changes, BUT, this “phase II”
needs approval. Anticipated charge of 7 to 9 billion in Q4. Of this
charge, about 2 billion will affect Cash.
- Expects
return of profitability and cash flow in F2002. Lucent is asking for
changes to covenant agreements. (I think Lucent wants to take a massive
charge, which would reduce book value and hence violates covenants. Lucent
was firm that they were NOT looking for more funds. I think they just want
to take a one-time hit and put all garbage behind them).
- Expects
Q4’01 sequential improvement on bottom line, no comment on top line.
- Ahead of all 7-point plan except for
vendor financing write-offs.
- Phase
2 will be implemented when covenants are modified.
Questions and Answers
- Fiber
sales Quarter to Quarter were essentially flat.
- One
10 % customer in quarter.
- Pension
credit of 400 million. This increased operating income. This has been
consistent with prior quarters.
- Breakeven
revenue number was asked. Lucent preferred not to answer, not prepared for
guidance.
- Target
of profitability in F2002. Hence there must be some type of internal
projections. Lucent commented by saying we are looking at a smaller,
leaner, less costing company. Mentioned that R & D will be about 12 %
of revenues. Lucent is not prepared to guide for top line. Yet, Lucent
says, “This shouldn’t be rocket science to figure out revenue
numbers”. Lucent further commented
that revenue growth is not a requirement for cash flow or eps
positive. (My words…. this will be
the topics for months to come…. revenue target is hinted, yet margin of
error is huge without mentioning dollars and only %’s of R&D.)